Search - tctmd.com

Displaying 601 - 620 of 1432

Sort: Relevancy | Date

Presentation TCT 2014

Hematologic Etiologies of Stent Thrombosis and How to Evaluate

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Giulio G. Stefanini

September 14, 2014

Presentation TCT 2014

Evaluation and Treatment of Stent Thrombosis: From Acute Patency to Long-term Vascular Stability

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Ron Waksman

September 14, 2014

Presentation TCT 2014

TCT 642: Stent Thrombosis Rates with an Abluminal Biodegradable Polymer, Biolimus-Eluting Stent Versus a Durable Polymer, Everolimus-Eluting Stent in Patients Undergoing Percutaneous Coronary Intervention: 3-Year Follow-up from the COMPARE II Trial

Presenter: Pieter C. Smits

September 14, 2014

Presentation TCT 2014

TCT 643: Very Late Stent Thrombosis After Revascularization with the Biolimus-Eluting, Biodegradable Polymer-Coated Nobori Stent Versus Durable Polymer-Coated, Sirolimus-Eluting Stents from the SORT-OUT V Trial

Presenter: Evald H. Christiansen

September 14, 2014

Presentation TCT 2014

Follow the Data: Fluorinated Polymer-Based DES are Safer than Bioresorbable-Based DES!

Presenter: Hyo-Soo Kim

September 14, 2014

Presentation TCT 2014

Bioresorbable Polymer-Based DES are the Right Choice to Minimize Stent Thrombosis!

Presenter: Stephan Windecker

September 14, 2014

Presentation TCT 2014

Are Current DES Really Safer Than BMS?

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Tullio Palmerini

September 14, 2014

Presentation TCT 2014

Beyond the Guidelines: What Is the Optimal Duration of DAPT After Metallic DES Implantation, and Is It Device Specific?

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Marco Valgimigli

September 14, 2014

Presentation TCT 2014

Prevention of Stent Thrombosis: Devices, Pharmacology, Technique, Patients, and More

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Lorenz Raber

September 14, 2014

Presentation TCT 2014

TCT 641: Improved Safety and Reduction in Stent Thrombosis After Everolimus-Eluting Stents Versus Sirolimus-Eluting Stents in Patients with Coronary Artery Disease: SORT-OUT IV 5-Year Results

Presenter: Donald Cutlip, Manel Sabate, Elvin Kedhi, Lisette Okkels Jensen

September 14, 2014

Presentation TCT 2014

Case #1: Retroperitoneal Hematoma and External Iliac Artery Thrombosis After Primary PCI

Presenter: Mahmoud Hashemian, Ajay J. Kirtane, Mohammad Ali Ostovan, Hrvoje Pintaric

September 14, 2014

News Conference News TCT 2014

Pooled Trial Data Show No Stent Thrombosis Reduction with Biodegradable Stent

September 14, 2014

News Conference News TCT 2014

PFO Closure for Stroke: A Call to Revise the Guidelines

September 14, 2014

News Conference News TCT 2014

OCT STEMI: Imaging-Guided PCI Shows Promise

September 14, 2014

News Industry News

New Study Assesses the Utility of Optical Coherence Tomography During Stent Implantation in Primary PCI

September 14, 2014

News Conference News TCT 2014

EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion

September 14, 2014

News Conference News TCT 2014

COMPARE II: STEMI Patients See Strong Results with Both BES and EES

September 14, 2014

News Conference News TCT 2014

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Yael L. Maxwell

September 14, 2014

News Industry News

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

September 14, 2014

News Conference News TCT 2014

ABSORB EXTEND: BVS Safe Out to 3 Years

September 14, 2014

Advertisement

Hematologic Etiologies of Stent Thrombosis and How to Evaluate

Evaluation and Treatment of Stent Thrombosis: From Acute Patency to Long-term Vascular Stability

TCT 642: Stent Thrombosis Rates with an Abluminal Biodegradable Polymer, Biolimus-Eluting Stent Versus a Durable Polymer, Everolimus-Eluting Stent in Patients Undergoing Percutaneous Coronary Intervention: 3-Year Follow-up from the COMPARE II Trial

TCT 643: Very Late Stent Thrombosis After Revascularization with the Biolimus-Eluting, Biodegradable Polymer-Coated Nobori Stent Versus Durable Polymer-Coated, Sirolimus-Eluting Stents from the SORT-OUT V Trial

Follow the Data: Fluorinated Polymer-Based DES are Safer than Bioresorbable-Based DES!

Bioresorbable Polymer-Based DES are the Right Choice to Minimize Stent Thrombosis!

Are Current DES Really Safer Than BMS?

Beyond the Guidelines: What Is the Optimal Duration of DAPT After Metallic DES Implantation, and Is It Device Specific?

Prevention of Stent Thrombosis: Devices, Pharmacology, Technique, Patients, and More

TCT 641: Improved Safety and Reduction in Stent Thrombosis After Everolimus-Eluting Stents Versus Sirolimus-Eluting Stents in Patients with Coronary Artery Disease: SORT-OUT IV 5-Year Results

Case #1: Retroperitoneal Hematoma and External Iliac Artery Thrombosis After Primary PCI

Pooled Trial Data Show No Stent Thrombosis Reduction with Biodegradable Stent

PFO Closure for Stroke: A Call to Revise the Guidelines

OCT STEMI: Imaging-Guided PCI Shows Promise

New Study Assesses the Utility of Optical Coherence Tomography During Stent Implantation in Primary PCI

EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion

COMPARE II: STEMI Patients See Strong Results with Both BES and EES

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

ABSORB EXTEND: BVS Safe Out to 3 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content